Welcome to Epivantage
Mission: Delivering robust epidemiological forecasts and insights
Epivantage was founded with the objective to improve the quality and level of granularity of the epidemiological forecast models and associated reports that are the foundation of pharmaceutical market assessment activities.
Using a combination of real-world evidence, tried-and-tested mathematical models and the decades of expertise of our leadership team, Epivantage delivers the highest-quality insights and data while remaining cost-effective, and with a rapid turnaround.
Our on-demand Cancer Populations USA and Global Cancer Epidemiology Forecast reports series can be tailored to any tumor specification and typically delivered within 1 to 3 weeks, with similar time frames for bespoke projects in other diseases.
We’re Hiring!
Positions available:
- Epidemiologist and Systematic Reviewer (job description)
- Research Assistant (job description)
Click on each role to view the job description. For interested applicants, please see the job description for details on application procedure.
Our range of services
Our off-the-shelf Cancer Populations USA and on-demand Global Cancer Epidemiology Forecast report series provide our clients with industry-leading and robustly researched information.
Our custom reports are likewise the result of in-depth primary and secondary research, and our consulting service provides clients with expertise in the design and execution of real-world evidence and epidemiological studies.
To request a free sample report, please complete this form. For all other inquiries, please email us at questions@epivantage.com, or use our inquiry form.
Epivantage leadership
Epivantage was founded in 2021 by Dr Mike Hughes who, over many years supporting pharma companies, created many of the advanced techniques for epidemiological forecasting. Epivantage applies these gold-standard methods to fine-grained epidemiological forecasts with the incorporation of real-world evidence and genetically-defined tumour populations.
Epivantage has a network of epidemiologists that regularly survey the evidence landscape to support their forecast models and insights. The resulting reports created by Epivantage fulfil the needs of modern pharma companies for reliable and up-to-date insights to support their strategic planning and market access plans.
Contact us with any questions.
